Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands

Kaposi's sarcoma-associated herpesvirus (KSHV), the etiological agent of Kaposi's sarcoma, belongs to the family, whose members employ a multicomponent terminase to resolve nonparametric viral DNA into genome-length units prior to their packaging. Homology modeling of the ORF29 C-terminal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial agents and chemotherapy 2018-10, Vol.62 (10)
Hauptverfasser: Miller, Jennifer T, Zhao, Haiyan, Masaoka, Takashi, Varnado, Brittany, Cornejo Castro, Elena M, Marshall, Vickie A, Kouhestani, Kaivon, Lynn, Anna Y, Aron, Keith E, Xia, Anqi, Beutler, John A, Hirsch, Danielle R, Tang, Liang, Whitby, Denise, Murelli, Ryan P, Le Grice, Stuart F J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 10
container_start_page
container_title Antimicrobial agents and chemotherapy
container_volume 62
creator Miller, Jennifer T
Zhao, Haiyan
Masaoka, Takashi
Varnado, Brittany
Cornejo Castro, Elena M
Marshall, Vickie A
Kouhestani, Kaivon
Lynn, Anna Y
Aron, Keith E
Xia, Anqi
Beutler, John A
Hirsch, Danielle R
Tang, Liang
Whitby, Denise
Murelli, Ryan P
Le Grice, Stuart F J
description Kaposi's sarcoma-associated herpesvirus (KSHV), the etiological agent of Kaposi's sarcoma, belongs to the family, whose members employ a multicomponent terminase to resolve nonparametric viral DNA into genome-length units prior to their packaging. Homology modeling of the ORF29 C-terminal nuclease domain (pORF29C) and bacteriophage Sf6 gp2 have suggested an active site clustered with four acidic residues, D , E , D , and D , that collectively sequester the catalytic divalent metal (Mn ) and also provided important insight into a potential inhibitor binding mode. Using this model, we have expressed, purified, and characterized the wild-type pORF29C and variants with substitutions at the proposed active-site residues. Differential scanning calorimetry demonstrated divalent metal-induced stabilization of wild-type (WT) and D A pORF29C, consistent with which these two enzymes exhibited Mn -dependent nuclease activity, although the latter mutant was significantly impaired. Thermal stability of WT and D A pORF29C was also enhanced by binding of an α-hydroxytropolone (α-HT) inhibitor shown to replace divalent metal at the active site. For the remaining mutants, thermal stability was unaffected by divalent metal or α-HT binding, supporting their role in catalysis. pORF29C nuclease activity was also inhibited by two classes of small molecules reported to inhibit HIV RNase H and integrase, both of which belong to the superfamily of nucleotidyltransferases. Finally, α-HT inhibition of KSHV replication suggests ORF29 nuclease function as an antiviral target that could be combined with latency-activating compounds as a shock-and-kill antiviral strategy.
doi_str_mv 10.1128/AAC.00233-18
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6153795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2080842830</sourcerecordid><originalsourceid>FETCH-LOGICAL-a484t-5daa67c217a1a6c190781099838b907712de78192fc8021280827db3af92588b3</originalsourceid><addsrcrecordid>eNp1kc1v1DAQxS0Eokvhxhn5BkhNsZ0v54IUBUorVlRil7M160xaV0m8eJJFvfOH4-2Wih44eTz--T3NPMZeS3EqpdIf6ro5FUKlaSL1E7aQotJJkVfFU7YQoiiSTIvsiL0guhHxnlfiOTtKYyVVqRfs9wpHcpPbuemW-45P18ibZI1hcCP0_NtsewRC_skP4MY98RW2ntxb4isINnaTmshbBxO2_BzDFmnnwkz88vuZqvjk-fqX500PREj7_7WNbpis3IR86a5gbOkle9ZBT_jq_jxmP84-r5vzZHn55aKplwlkOpuSvAUoSqtkCRIKKytR6jhupVO9iXUpVYuxU6nOaqHiboRWZbtJoatUrvUmPWYfD7rbeTNga3GcAvRmG9wA4dZ4cObxy-iuzZXfmULmaVnlUeDdvUDwP2ekyQyOLPY9jOhnMkpEz0zpVET05IDa4IkCdg82Uph9cCYGZ-6CM1JH_P0BBxqUufFziOun_7Fv_h3jQfhvqukfKPGf0Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2080842830</pqid></control><display><type>article</type><title>Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Miller, Jennifer T ; Zhao, Haiyan ; Masaoka, Takashi ; Varnado, Brittany ; Cornejo Castro, Elena M ; Marshall, Vickie A ; Kouhestani, Kaivon ; Lynn, Anna Y ; Aron, Keith E ; Xia, Anqi ; Beutler, John A ; Hirsch, Danielle R ; Tang, Liang ; Whitby, Denise ; Murelli, Ryan P ; Le Grice, Stuart F J</creator><creatorcontrib>Miller, Jennifer T ; Zhao, Haiyan ; Masaoka, Takashi ; Varnado, Brittany ; Cornejo Castro, Elena M ; Marshall, Vickie A ; Kouhestani, Kaivon ; Lynn, Anna Y ; Aron, Keith E ; Xia, Anqi ; Beutler, John A ; Hirsch, Danielle R ; Tang, Liang ; Whitby, Denise ; Murelli, Ryan P ; Le Grice, Stuart F J</creatorcontrib><description>Kaposi's sarcoma-associated herpesvirus (KSHV), the etiological agent of Kaposi's sarcoma, belongs to the family, whose members employ a multicomponent terminase to resolve nonparametric viral DNA into genome-length units prior to their packaging. Homology modeling of the ORF29 C-terminal nuclease domain (pORF29C) and bacteriophage Sf6 gp2 have suggested an active site clustered with four acidic residues, D , E , D , and D , that collectively sequester the catalytic divalent metal (Mn ) and also provided important insight into a potential inhibitor binding mode. Using this model, we have expressed, purified, and characterized the wild-type pORF29C and variants with substitutions at the proposed active-site residues. Differential scanning calorimetry demonstrated divalent metal-induced stabilization of wild-type (WT) and D A pORF29C, consistent with which these two enzymes exhibited Mn -dependent nuclease activity, although the latter mutant was significantly impaired. Thermal stability of WT and D A pORF29C was also enhanced by binding of an α-hydroxytropolone (α-HT) inhibitor shown to replace divalent metal at the active site. For the remaining mutants, thermal stability was unaffected by divalent metal or α-HT binding, supporting their role in catalysis. pORF29C nuclease activity was also inhibited by two classes of small molecules reported to inhibit HIV RNase H and integrase, both of which belong to the superfamily of nucleotidyltransferases. Finally, α-HT inhibition of KSHV replication suggests ORF29 nuclease function as an antiviral target that could be combined with latency-activating compounds as a shock-and-kill antiviral strategy.</description><identifier>ISSN: 0066-4804</identifier><identifier>ISSN: 1098-6596</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.00233-18</identifier><identifier>PMID: 30061278</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Antiviral Agents ; Calorimetry, Differential Scanning ; Catalytic Domain ; DNA, Viral - genetics ; Endodeoxyribonucleases - genetics ; Endonucleases ; Endonucleases - chemistry ; Endonucleases - genetics ; Endonucleases - metabolism ; Enzyme Activation - drug effects ; Herpesvirus 8, Human ; Herpesvirus 8, Human - enzymology ; Herpesvirus 8, Human - genetics ; HIV Integrase Inhibitors - pharmacology ; Integrases - genetics ; Mutagenesis, Site-Directed ; Open Reading Frames - genetics ; Protein Structure, Secondary ; Ribonuclease H - genetics ; Sarcoma, Kaposi ; Sarcoma, Kaposi - virology</subject><ispartof>Antimicrobial agents and chemotherapy, 2018-10, Vol.62 (10)</ispartof><rights>Copyright © 2018 American Society for Microbiology.</rights><rights>Copyright © 2018 American Society for Microbiology. 2018 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a484t-5daa67c217a1a6c190781099838b907712de78192fc8021280827db3af92588b3</citedby><cites>FETCH-LOGICAL-a484t-5daa67c217a1a6c190781099838b907712de78192fc8021280827db3af92588b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153795/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153795/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30061278$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miller, Jennifer T</creatorcontrib><creatorcontrib>Zhao, Haiyan</creatorcontrib><creatorcontrib>Masaoka, Takashi</creatorcontrib><creatorcontrib>Varnado, Brittany</creatorcontrib><creatorcontrib>Cornejo Castro, Elena M</creatorcontrib><creatorcontrib>Marshall, Vickie A</creatorcontrib><creatorcontrib>Kouhestani, Kaivon</creatorcontrib><creatorcontrib>Lynn, Anna Y</creatorcontrib><creatorcontrib>Aron, Keith E</creatorcontrib><creatorcontrib>Xia, Anqi</creatorcontrib><creatorcontrib>Beutler, John A</creatorcontrib><creatorcontrib>Hirsch, Danielle R</creatorcontrib><creatorcontrib>Tang, Liang</creatorcontrib><creatorcontrib>Whitby, Denise</creatorcontrib><creatorcontrib>Murelli, Ryan P</creatorcontrib><creatorcontrib>Le Grice, Stuart F J</creatorcontrib><title>Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands</title><title>Antimicrobial agents and chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Kaposi's sarcoma-associated herpesvirus (KSHV), the etiological agent of Kaposi's sarcoma, belongs to the family, whose members employ a multicomponent terminase to resolve nonparametric viral DNA into genome-length units prior to their packaging. Homology modeling of the ORF29 C-terminal nuclease domain (pORF29C) and bacteriophage Sf6 gp2 have suggested an active site clustered with four acidic residues, D , E , D , and D , that collectively sequester the catalytic divalent metal (Mn ) and also provided important insight into a potential inhibitor binding mode. Using this model, we have expressed, purified, and characterized the wild-type pORF29C and variants with substitutions at the proposed active-site residues. Differential scanning calorimetry demonstrated divalent metal-induced stabilization of wild-type (WT) and D A pORF29C, consistent with which these two enzymes exhibited Mn -dependent nuclease activity, although the latter mutant was significantly impaired. Thermal stability of WT and D A pORF29C was also enhanced by binding of an α-hydroxytropolone (α-HT) inhibitor shown to replace divalent metal at the active site. For the remaining mutants, thermal stability was unaffected by divalent metal or α-HT binding, supporting their role in catalysis. pORF29C nuclease activity was also inhibited by two classes of small molecules reported to inhibit HIV RNase H and integrase, both of which belong to the superfamily of nucleotidyltransferases. Finally, α-HT inhibition of KSHV replication suggests ORF29 nuclease function as an antiviral target that could be combined with latency-activating compounds as a shock-and-kill antiviral strategy.</description><subject>Antiviral Agents</subject><subject>Calorimetry, Differential Scanning</subject><subject>Catalytic Domain</subject><subject>DNA, Viral - genetics</subject><subject>Endodeoxyribonucleases - genetics</subject><subject>Endonucleases</subject><subject>Endonucleases - chemistry</subject><subject>Endonucleases - genetics</subject><subject>Endonucleases - metabolism</subject><subject>Enzyme Activation - drug effects</subject><subject>Herpesvirus 8, Human</subject><subject>Herpesvirus 8, Human - enzymology</subject><subject>Herpesvirus 8, Human - genetics</subject><subject>HIV Integrase Inhibitors - pharmacology</subject><subject>Integrases - genetics</subject><subject>Mutagenesis, Site-Directed</subject><subject>Open Reading Frames - genetics</subject><subject>Protein Structure, Secondary</subject><subject>Ribonuclease H - genetics</subject><subject>Sarcoma, Kaposi</subject><subject>Sarcoma, Kaposi - virology</subject><issn>0066-4804</issn><issn>1098-6596</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1v1DAQxS0Eokvhxhn5BkhNsZ0v54IUBUorVlRil7M160xaV0m8eJJFvfOH4-2Wih44eTz--T3NPMZeS3EqpdIf6ro5FUKlaSL1E7aQotJJkVfFU7YQoiiSTIvsiL0guhHxnlfiOTtKYyVVqRfs9wpHcpPbuemW-45P18ibZI1hcCP0_NtsewRC_skP4MY98RW2ntxb4isINnaTmshbBxO2_BzDFmnnwkz88vuZqvjk-fqX500PREj7_7WNbpis3IR86a5gbOkle9ZBT_jq_jxmP84-r5vzZHn55aKplwlkOpuSvAUoSqtkCRIKKytR6jhupVO9iXUpVYuxU6nOaqHiboRWZbtJoatUrvUmPWYfD7rbeTNga3GcAvRmG9wA4dZ4cObxy-iuzZXfmULmaVnlUeDdvUDwP2ekyQyOLPY9jOhnMkpEz0zpVET05IDa4IkCdg82Uph9cCYGZ-6CM1JH_P0BBxqUufFziOun_7Fv_h3jQfhvqukfKPGf0Q</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Miller, Jennifer T</creator><creator>Zhao, Haiyan</creator><creator>Masaoka, Takashi</creator><creator>Varnado, Brittany</creator><creator>Cornejo Castro, Elena M</creator><creator>Marshall, Vickie A</creator><creator>Kouhestani, Kaivon</creator><creator>Lynn, Anna Y</creator><creator>Aron, Keith E</creator><creator>Xia, Anqi</creator><creator>Beutler, John A</creator><creator>Hirsch, Danielle R</creator><creator>Tang, Liang</creator><creator>Whitby, Denise</creator><creator>Murelli, Ryan P</creator><creator>Le Grice, Stuart F J</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20181001</creationdate><title>Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands</title><author>Miller, Jennifer T ; Zhao, Haiyan ; Masaoka, Takashi ; Varnado, Brittany ; Cornejo Castro, Elena M ; Marshall, Vickie A ; Kouhestani, Kaivon ; Lynn, Anna Y ; Aron, Keith E ; Xia, Anqi ; Beutler, John A ; Hirsch, Danielle R ; Tang, Liang ; Whitby, Denise ; Murelli, Ryan P ; Le Grice, Stuart F J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a484t-5daa67c217a1a6c190781099838b907712de78192fc8021280827db3af92588b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antiviral Agents</topic><topic>Calorimetry, Differential Scanning</topic><topic>Catalytic Domain</topic><topic>DNA, Viral - genetics</topic><topic>Endodeoxyribonucleases - genetics</topic><topic>Endonucleases</topic><topic>Endonucleases - chemistry</topic><topic>Endonucleases - genetics</topic><topic>Endonucleases - metabolism</topic><topic>Enzyme Activation - drug effects</topic><topic>Herpesvirus 8, Human</topic><topic>Herpesvirus 8, Human - enzymology</topic><topic>Herpesvirus 8, Human - genetics</topic><topic>HIV Integrase Inhibitors - pharmacology</topic><topic>Integrases - genetics</topic><topic>Mutagenesis, Site-Directed</topic><topic>Open Reading Frames - genetics</topic><topic>Protein Structure, Secondary</topic><topic>Ribonuclease H - genetics</topic><topic>Sarcoma, Kaposi</topic><topic>Sarcoma, Kaposi - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miller, Jennifer T</creatorcontrib><creatorcontrib>Zhao, Haiyan</creatorcontrib><creatorcontrib>Masaoka, Takashi</creatorcontrib><creatorcontrib>Varnado, Brittany</creatorcontrib><creatorcontrib>Cornejo Castro, Elena M</creatorcontrib><creatorcontrib>Marshall, Vickie A</creatorcontrib><creatorcontrib>Kouhestani, Kaivon</creatorcontrib><creatorcontrib>Lynn, Anna Y</creatorcontrib><creatorcontrib>Aron, Keith E</creatorcontrib><creatorcontrib>Xia, Anqi</creatorcontrib><creatorcontrib>Beutler, John A</creatorcontrib><creatorcontrib>Hirsch, Danielle R</creatorcontrib><creatorcontrib>Tang, Liang</creatorcontrib><creatorcontrib>Whitby, Denise</creatorcontrib><creatorcontrib>Murelli, Ryan P</creatorcontrib><creatorcontrib>Le Grice, Stuart F J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial agents and chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miller, Jennifer T</au><au>Zhao, Haiyan</au><au>Masaoka, Takashi</au><au>Varnado, Brittany</au><au>Cornejo Castro, Elena M</au><au>Marshall, Vickie A</au><au>Kouhestani, Kaivon</au><au>Lynn, Anna Y</au><au>Aron, Keith E</au><au>Xia, Anqi</au><au>Beutler, John A</au><au>Hirsch, Danielle R</au><au>Tang, Liang</au><au>Whitby, Denise</au><au>Murelli, Ryan P</au><au>Le Grice, Stuart F J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands</atitle><jtitle>Antimicrobial agents and chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>62</volume><issue>10</issue><issn>0066-4804</issn><issn>1098-6596</issn><eissn>1098-6596</eissn><abstract>Kaposi's sarcoma-associated herpesvirus (KSHV), the etiological agent of Kaposi's sarcoma, belongs to the family, whose members employ a multicomponent terminase to resolve nonparametric viral DNA into genome-length units prior to their packaging. Homology modeling of the ORF29 C-terminal nuclease domain (pORF29C) and bacteriophage Sf6 gp2 have suggested an active site clustered with four acidic residues, D , E , D , and D , that collectively sequester the catalytic divalent metal (Mn ) and also provided important insight into a potential inhibitor binding mode. Using this model, we have expressed, purified, and characterized the wild-type pORF29C and variants with substitutions at the proposed active-site residues. Differential scanning calorimetry demonstrated divalent metal-induced stabilization of wild-type (WT) and D A pORF29C, consistent with which these two enzymes exhibited Mn -dependent nuclease activity, although the latter mutant was significantly impaired. Thermal stability of WT and D A pORF29C was also enhanced by binding of an α-hydroxytropolone (α-HT) inhibitor shown to replace divalent metal at the active site. For the remaining mutants, thermal stability was unaffected by divalent metal or α-HT binding, supporting their role in catalysis. pORF29C nuclease activity was also inhibited by two classes of small molecules reported to inhibit HIV RNase H and integrase, both of which belong to the superfamily of nucleotidyltransferases. Finally, α-HT inhibition of KSHV replication suggests ORF29 nuclease function as an antiviral target that could be combined with latency-activating compounds as a shock-and-kill antiviral strategy.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>30061278</pmid><doi>10.1128/AAC.00233-18</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial agents and chemotherapy, 2018-10, Vol.62 (10)
issn 0066-4804
1098-6596
1098-6596
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6153795
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Antiviral Agents
Calorimetry, Differential Scanning
Catalytic Domain
DNA, Viral - genetics
Endodeoxyribonucleases - genetics
Endonucleases
Endonucleases - chemistry
Endonucleases - genetics
Endonucleases - metabolism
Enzyme Activation - drug effects
Herpesvirus 8, Human
Herpesvirus 8, Human - enzymology
Herpesvirus 8, Human - genetics
HIV Integrase Inhibitors - pharmacology
Integrases - genetics
Mutagenesis, Site-Directed
Open Reading Frames - genetics
Protein Structure, Secondary
Ribonuclease H - genetics
Sarcoma, Kaposi
Sarcoma, Kaposi - virology
title Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A47%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sensitivity%20of%20the%20C-Terminal%20Nuclease%20Domain%20of%20Kaposi's%20Sarcoma-Associated%20Herpesvirus%20ORF29%20to%20Two%20Classes%20of%20Active-Site%20Ligands&rft.jtitle=Antimicrobial%20agents%20and%20chemotherapy&rft.au=Miller,%20Jennifer%20T&rft.date=2018-10-01&rft.volume=62&rft.issue=10&rft.issn=0066-4804&rft.eissn=1098-6596&rft_id=info:doi/10.1128/AAC.00233-18&rft_dat=%3Cproquest_pubme%3E2080842830%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2080842830&rft_id=info:pmid/30061278&rfr_iscdi=true